Fractyl Health (GUTS) Inventory Average (2024)

Fractyl Health's (GUTS) quarterly Inventory Average came in at $73000.0 in Q4 2024, up 6.57% on a QoQ basis from $68500.0 in Q3 2024.

Fractyl Health (GUTS) Inventory Average (2024) Analysis & Trends

Fractyl Health (GUTS) has 1 years of Inventory Average data on file, last reported at $73000.0 in Q4 2024.

Quarterly Inventory Average changed N/A year-over-year to $73000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $73000.0 (changed N/A YoY) and the FY2024 annual result came in at $73000.0, changed N/A from the prior year.
Inventory Average advanced to $73000.0 in Q4 2024, from $68500.0 in the prior quarter.
In the past five years, Inventory Average ranged from a high of $73000.0 in Q1 2024 to a low of $68500.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	139.96 Bn	132.11 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	86.79 Bn	78.79 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	65.22 Bn	60.03 Bn	1.37 Bn	-
4	Moderna	60.20 Bn	55.06 Bn	52.00 Mn	213.00 Mn
5	BeOne Medicines	42.19 Bn	37.09 Bn	1.53 Bn	707.10 Mn
6	Alnylam Pharmaceuticals	31.43 Bn	28.12 Bn	992.69 Mn	90.57 Mn
7	BioNTech SE	28.65 Bn	10.26 Bn	668.28 Mn	196.36 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	137.65 Mn
9	Royalty Pharma	27.16 Bn	26.32 Bn	-	-
10	Fractyl Health	122.18 Mn	122.18 Mn	-	-

Download Data